Tony Barr says he works outside the network of Bridgeport nonprofits that are focused on helping the second-chance community. "They do a good job, but they can't help everyone -- and that's where I ...

Gut bacteria aren’t just passive passengers—they can actively send proteins straight into our cells. Using microscopic injection systems, even harmless microbes can influence immune responses and ...

The National Health Insurance Act was signed into law in May 2024 but its rollout is paused over legal challenges. Critics have raised concerns about corruption, unclear funding plans and what the NHI ...

Even with maximum emergency measures, the world could face a supply deficit exceeding 10 million barrels per day. Strategic reserves and alternative pipelines provide only temporary and partial relief ...

It cannot be ruled out that Noah Donohoe may have had drugs in his system at the time of his death, toxicologists have told an inquest. Forensic analysts said there was no evidence that the schoolboy ...

We may receive a commission on purchases made from links. Growing your own veggies and herbs is a fun way to get fresh, local produce and even save money on food costs. So, it's not surprising that ...

Altoona Area senior Aleah Dively works on wrapping 24 simulated hamburgers Thursday in the high school’s Practical Assessment Exploration System lab. The PAES lab is designed to help special education ...

GM has reportedly developed a new ordering program called CoreBuild, which provides dealers with the most popular car builds. GM is testing CoreBuild, streamlining dealer ordering with 26 popular ...

Claire Henry receives funding from the Australian Research Council as a DECRA Fellow. She previously received a research grant from InternetNZ (2018) for an unrelated project on "Preventing child ...

President Donald Trump paid a visit to UFC 327 on Saturday night at the Kaseya Center in Miami, taking a front-row seat alongside UFC president Dana White. Driver arrested after Florida traffic stop ...

Although it looked to be lights out for InflaRx’s C5a antibody vilobelimab in the rare skin disorder pyoderma gangrenosum (PG) last year, the German drugmaker ended 2025 with a glimmer of hope for the ...